JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2006) 190, 461-470       DOI: 10.1677/joe.1.06794
© 2006 Society for Endocrinology
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gustavsson, N.
Right arrow Articles by Lindström, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gustavsson, N.
Right arrow Articles by Lindström, P.

Cell specificity of the cytoplasmic Ca2+ response to tolbutamide is impaired in ß-cells from hyperglycemic mice

Natalia Gustavsson, Gerd Larsson-Nyrén and Per Lindström

Department of Integrative Medical Biology, Section for Histology and Cell Biology, Umeå University, Umeå S-901 87, Sweden

(Requests for offprints should be addressed to N Gustavsson; Email: natalia.gustavsson{at}histocel.umu.se)


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We recently reported that the timing and magnitude of the nutrient-induced Ca2+ response are specific and reproducible for each isolated ß-cell. We have now used tolbutamide and arginine to test if the cell specificity exists also for the response to non-nutrient stimulation of ß-cells and if so, whether it is disturbed in ß-cells from hyperglycemic ob/ob and db/db mice. Zn2+ outflow measurements were used to study the correlation between Ca2+ response and insulin secretion in individual ß-cells. Tolbutamide and arginine induced cell-specific Ca2+ responses in lean mouse ß-cells both with regard to lag times for [Ca2+]i rise and peak [Ca2+]i heights. ß-Cells within intact islets also showed cell-specific timing of their Ca2+ responses to tolbutamide. However, in tolbutamide- and arginine-stimulated single ß-cells from ob/ob and db/db mice only the magnitude of Ca2+ response was cell-specific, not the timing. The lag time of tolbutamide-induced insulin secretion was cell-specific in lean mouse ß-cells but not in ob/ob mouse cells. Therefore, cell specificity seems to be a robust mechanism, and probably important for an adequate ß-cell function. The loss of temporal cell specificity for the response to tolbutamide in single ß-cells from hyperglycemic mice may be a sign of KATP- or voltage-dependent calcium channel dysfunction.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Despite a large number of studies on the pathogenesis of type-2 diabetes, the precise mechanism of ß-cell dysfunction remains unclear. It is known that insulin and Ca2+response is delayed and reduced in patients and animal models with type-2 diabetes and the coordination of function of ß-cells is disturbed (Cerasi et al. 1972, Porte 1991). ß-Cells form clusters in pancreatic islets, where they are functionally linked by gap junctions (Salomon & Meda 1986) and other types of cell communication (Hellman et al. 2004), which results in a spread of signal within an islet. Isolated ß-cells and small cell clusters show a high degree of functional heterogeneity (Pralong et al. 1990, Herchuelz et al. 1991, Pipeleers et al. 1994). We recently reported that nutrient-induced Ca2+and NADH response patterns are also cell-specific, i.e., reproducible with regard to timing and magnitude of response (Larsson-Nyrén et al. 2002, Pakhtusova et al. 2003, Gustavsson et al. 2005). However, the cell specificity of mitochondrial metabolism seems to be blunted in diabetes and obesity (Gustavsson et al. 2005). We have now used tolbutamide and arginine to test if cell-specific responses can be observed also with non-nutrient stimuli, which affect voltage-dependent plasma membrane ion channels and if so, whether they are disturbed in ob/ob and db/db mouse ß-cells. Tolbutamide blocks ß-cell KATP channels by a direct interaction with sulfonylurea (SUR1) receptors (Trube et al. 1986, Ashcroft & Ashcroft 1992) and arginine directly causes ß-cell depolarization (Charles et al. 1982, Herchuelz et al. 1984). In diabetic subjects, the ß-cell response to sulfonylureas is less impaired than the response to glucose (Del Guerra et al. 2005). db/db mice develop severe diabetes (Berglund et al. 1978) and their ß-cells show a defective Ca2+ response to glucose stimulation (Roe et al. 1994). ob/ob mice are hyperglycemic, but their ß-cells respond adequately in vitro to stimulators and inhibitors of insulin release (Hellman et al. 1974, Idahl et al. 1976). However, a disorganization of the response within islets has been reported in the ob/ob mouse (Ravier et al. 2002). We used recordings of Zn2+ outflow as a measure of insulin secretion (Qian et al. 2003) to study the correlation between Ca2+ and Zn2+ response patterns in individual ß-cells during the first and second stimulation.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals

Adult female lean and Umeå ob/ob mice were from a local colony and female db/db mice (BKS.Cg-m+/+Leprdb) were from Taconic Europe, Ry, Denmark. db/db mice were brought to our animal care facility at the age of 6 weeks and were housed until 3–4 months old, when the diabetic condition becomes manifest, but not prolonged. Principles of laboratory animal care (National Institute of Health publication no. 83-25, revised 1985) were followed and the animal care and experimental procedures were carried out in accordance with the standards established by the European Communities Council Directive (86/609/EEC9). The experiments were also approved by the Northern Swedish Committee for Ethics in Animal Experiments.

In overnight-fasted db/db mice, the blood sugar level was 22±2 mM (mean±S.D., n=33). This is in line with earlier observations (Berglund et al. 1978, Gustavsson et al. 2005). The urinary glucose level was 17±2 mM (n=33). The blood sugar in overnight-fasted ob/ob mice was 7±0.4 mM (n=16), with negative urinary glucose. The blood sugar level of lean mice was 5±0.4 mM (n=15).

ß-Cell preparation

Single ß-cells were prepared by shaking collagenase-isolated islets in Ca2+-deficient medium supplemented with EGTA and DNAase (Roche, Mannheim, Germany) (Lernmark 1974). The cells were distributed on polylysine-coated cover glasses (Sigma Chemicals, Stockholm, Sweden) placed in Petri dishes and maintained in tissue culture for 24–48 h at 11.1 mM glucose in medium (RPMI 1640; Roche) supplemented with 10% heat-inactivated fetal calf serum (Gibco, Stockholm, Sweden), 60 mg/ml garamycin (Schering Co., Kenilworth, NJ, USA), 60 mg/ml benzylpenicillin (Schering Co.), and 2 mM L-glutamine (Labkemi AB, Stockholm, Sweden). Subsequent experimental handling was performed with a Krebs–Ringer medium (KRH, Gibco) having the following composition in mM: 130 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, and 2.56 CaCl2 and supplemented with 1 mg/ml BSA (Sigma Chemicals) and 3 mM D-glucose (Larsson-Nyrén & Sehlin 1996). The medium was buffered with 20 mM HEPES (Roche) and NaOH to pH of 7.4 and equilibrated with ambient air.

Measurements of cytoplasmic Ca2+ with Fura-2

Isolated cells were loaded with 1 µM Fura-2 (Molecular Probes Inc., Eugene, Oregon, USA) for 40 min in KRH medium at 37 °C. After rinsing in KRH to remove extracellular Fura-2, the cover glasses were mounted as the bottom of an open chamber (Larsson-Nyrén & Sehlin 1996). Experiments were performed using an image analysis system Openlab (Improvision, Coventry, West Midlands, UK) on an inverted microscope (Zeiss Axiovert, Gottingen, Germany) equipped for epifluorescence measurements. The cells were continuously perifused at a flow rate of 0.6 ml/min. The diameter of the perifusion chamber was 5 mm and volume of fluid in the chamber during perifusion was ~80 µl, which means that the whole volume was replaced within 8 s. The inflow tube was mounted close to the bottom at a distance of 1 mm from the center of the chamber.

Fura-2 was successively excited at the wavelengths 340 and 380 nm during 23 ms each using a 75 W Xenon lamp and a Polychrome IV monochromator (TILL Photonics, Murtinsried, Germany). The interval between cycles of 340 and 380 nm excitation was 1.75 s. Images were acquired by a camera (Orca ER, Hamamatsu, Japan). Temperature control (37 °C) was obtained by heating the chamber holder and the objective separately. The Ca2+ response was recorded from single ß-cells without direct contact with other cells. ß-Cells were initially preperifused at 3 mM glucose for 15 min. They were then stimulated twice with 100, 20 µM tolbutamide (Hoechst, Frankfurt, Germany), or 10 mM arginine during 10 min with a resting period of 30 min at 3 mM glucose between stimulations. All test media contained 3 mM glucose except in studies with 20 µM tolbutamide, which was applied in KRH medium containing 5 mM glucose to increase the number of responding cells (Jonkers et al. 2001). The duration of stimulation and the resting period were chosen to minimize time-dependent effects after the first stimulation (Nesher et al. 1989), but with sufficient time to recognize individual profiles also from cells that respond late (Larsson-Nyrén et al. 2002, Pakhtusova et al. 2003). Before the second stimulation, the exposed cell was checked by visual inspection. [Ca2+]i was calculated from the ratio of 340 and 380 nm signals after background subtraction using the equation described by Grynkiewicz et al.(1985), with a Kd of 224 nM.

Lag-time for [Ca2+]i rise during the first and second stimulation (LTr1 and LTr2) was defined as the time from the addition of stimulus to the first [Ca2+]i value above baseline average, calculated during the 3 min preceding the stimulation. Peak height during the first and second stimulation (PH1 and PH2) was calculated as the difference between the baseline and the highest [Ca2+]i value during the first peak. Superimposed spikes on top of the peaks were not included in calculations of peak height.

Insulin secretion measurements

ß-Cells were prepared as described above. Zn2+ images with FluoZin-3 (Molecular Probes Inc.) wereacquiredwith 488 nm excitation and 510 nm emission using the Openlab image analysis system on the Zeiss Axiovert microscope (see Measurements of cytoplasmic Ca2+ in ß-cells with Fura–2). Buffer with a reduced background Zn2+ level was made as described by Qian et al.(2003). Briefly, KRH was prepared with all ingredients except calcium and magnesium salts. The buffer was then treated with 5 g/dl Chelex-100 (Bio-Rad) for 2 h. The pH was adjusted to 7.4 after Chelex treatment and puratronic grade CaCl2 and MgSO4 (Alfa Aesar, Karlsruhe, Germany) were added to the final concentrations. Glass containers were avoided to minimize metal contamination. The Zn2+ chelator 200 nM tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN; Molecular Probes Inc.) was added. Glass slides for cell preparation were soaked in 2 mM EDTA for 2–4 days to minimize Zn2+ leaching during the experiments (Kay et al. 2004). Cover glasses with Fura-2 loaded cells were washed in 3 ml KRH containing 2 µM FluoZin-3 and then placed at the bottom of the open chamber and transferred to the microscope. KRH with FluoZin-3 (150 µl) was added to the chamber. To stimulate cells, 10 µl tolbutamide stock solution containing 2 µM FluoZin-3 were added to give a final concentration of 100 µM tolbutamide. Preliminary experiments showed that the final homogeneous concentration of the stimulator in the chamber was reached within 5 s. For controls, KRH buffer without tolbutamide was applied to the cells. FluoZin-3 fluorescence images were collected every 2 s and the average fluorescence intensities were measured after background subtraction in a region of interest (ROI) of ~20 µm around the cell periphery. Cells were identified by differential interference contrast (DIC) images before the measurement and by the low Zn–Fluozin background from the cell membrane. FluoZin-3 does not penetrate into the cell, presumably because of the three negative charges on the molecule at physiological pH (Gee et al. 2002, Kay et al. 2004). Cells were stimulated during 10 min, after which they were washed by perifusion with KRH containing 3 mM glucose during 30 min. Then, the cells were stimulated again, and [Ca2+]i was measured as described above. The microscope system does not allow a change of excitation exposure during simultaneous measurements. Therefore, attempts were not made to measure Zn2+ efflux and Ca2+ response simultaneously, because Zn2+ measurements required higher excitation intensity than calcium measurements with Fura-2. The wavelengths used for calcium measurements (380 and 340 nm) can be harmful for cells during intense exposure.

Confocal microscopy and measurements of cytoplasmic Ca2+ with Fluo-3

Experiments were performed using the Leica SP2 spectral laser scanning confocal microscopy system (Leica Microsystems, Mannheim, Germany). Measurements were performed with the technique similar to that described by Nadal et al.(1999). Intact islets were loaded with the calcium dye Fluo-3 for 90 min at room temperature and then placed on coverslips on the bottom of an open perifusion chamber always in the same part of the chamber close to the inflow tube. The chamber was put on the stage of the microscope and maintained at 37 °C. Islets were continuously superfused at a flow rate of 0.6 ml/min. Cells were first visualized using transmission laser scanning microscopy. Fluo-3 was excited with the 488 nm line of an argon laser. Fluo-3 responses were recorded from peripheral cells in one randomly chosen cross-section in islets using a Leica x40 oil immersion lens with numerical aperture 1.3. The pinhole was optimized for the x40 objective. The resulting fluorescence was recorded in a channel set up to detect emitted light in the range 510–600 nm. Islets were stimulated twice with 20 µM tolbutamide as described above. Images were collected at 2-s intervals, and fluorescence signals from individual cells were measured as a function of time by using the Leica Confocal Software (Heidelberg, Germany) package. Each image frame was examined to adjust the regions of interest for slight movements in cellular location. Images were analyzed and results were plotted using Leica Confocal Software. Fluo-3 is a nonratiometric dye and the fluorescence intensity varies with even minor experimental change. The calcium-dependent change in fluorescence is therefore expressed as arbitrary units.

Chemicals

Collagenase type I, HEPES, and poly-L-lysine were purchased from Boehringer (Mannheim, Germany). BSA, fraction V, EGTA, arginine and DNAase were all from Sigma Chemical Co. Culture medium RPMI 1640 was obtained from Gibco, and fetal calf serum was from Labkemi AB (Stockholm, Sweden). Benzylpenicillin and garamycin were from Schering Co. (Kenilworth, NJ, USA). Tolbutamide was from Hoechst AG (Frankfurt, Germany). Fura 2-AM, Fluo-3, FluoZin-3, and TPEN were from Molecular Probes Inc. (Eugene, OR, USA). Puratronic CaCl2 and MgSO4 were from Alfa Aesar (Karlsruhe, Germany). All other reagents were of analytical grade.

Statistical analysis

The data are presented as means±S.E.M. Comparisons of responses from the same cell during first and second stimulation were made using Student’s t-test for paired data and calculated correlation coefficients (Pearson correlation). The linear representative of the correlation was calculated using the least square method. For comparison between sets of experiments, two-tailed Student’s t-test for independent data was used. The significance limit was set at P<0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cell specificity of the ß-cell Ca2+ response to tolbutamide

Responses were most often registered in cells situated close to the center of the chamber. Control experiments have shown no differences in lag time for [Ca2+]i rise in cells situated in the central area and on the periphery of the chamber when cells were stimulated with high glucose (133±24 s (n=7) vs 158±21 s (n=12) respectively).

The average lag time for tolbutamide-induced [Ca2+]i rise is shorter than that for the response to glucose and unlike glucose, tolbutamide causes no initial lowering in [Ca2+]i (Grapengiesser et al. 1988). We tested 100 µM, which gives near maximal stimulation and 20 µM tolbutamide to find out if the lag time is concentration dependent. The lower concentration may provide more heterogeneous responses with regard to timing and reduce the risk for persisting effects that may influence the second response. Tolbutamide at 20 µM induced no response in most cells when tested together with 3 mM glucose (data not shown). Therefore, the glucose concentration was increased to 5 mM to increase the number of responding cells (Frederickson & Bush 2001). The lag time for calcium rise was longer with 20 µM than with 100 µM tolbutamide during the first stimulation in lean and ob/ob mouse ß-cells (Table 1Go, PGo<0.001 for lean mouse, P<0.005 for ob/ob mouse, P=0.11 for db/db mouse ß-cells). Timing of the response was cell-specific in ß-cells from lean but not from ob/ob or db/db mice both with 100 and 20 µM (Table 1Go). The lag time was shorter in db/db mouse ß-cells than in lean mouse ß-cells (Table 1Go). ß-Cells from ob/ob mice also reacted more promptly to stimulation with 100 µM tolbutamide than lean mouse ß-cells.


View this table:
[in this window]
[in a new window]
 
Table 1 Cell specificity of Ca2+ response to tolbutamide and arginine in lean, ob/ob, and db/db mouse ß-cells
 
Lean mouse ß-cells showed cell-specific peak heights both with 100 and 20 µM tolbutamide (Table 1Go). Ca2+responses in ob/ob and db/db mouse ß-cells are shown in Figs 1BGo and 2BGo and Figs 1CGo and 2CGo respectively. ß-Cells from db/db mice, as well as from ob/ob mice, showed a correlation between peak heights with 20 µM but not with 100 µM tolbutamide (Table 1Go). Basal [Ca2+]i levels were higher in db/db mouse ß-cells than in lean and ob/ob mouse ß-cells (122±13 nM, n=33 versus 54±6 nM, n=46 and 50±3 nM Ca2+, n=50 respectively, P<0.001 for both comparisons). The magnitude of response during the first stimulation (PH1) was the same in ob/ob mouse and lean mouse ß-cells. However, ob/ob mouse ß-cells showed a lower Ca2+ rise during the second stimulation than during the first one (Table 1Go).


Figure 1
View larger version (15K):
[in this window]
[in a new window]
 
Figure 1 Ca2+responses from a representative isolated ß-cell during two consecutive stimulations with 100 µM tolbutamide. (A, B and C) Recordings from the first (solid line) and second stimulations (dotted line) of (A) a lean, (B) ob/ob, and (C) db/db mouse ß-cell respectively. The resting period between stimulations was 30 min. (a–c) The correlation between lag times for [Ca2+]i rise during the first stimulation, LTr1 (x-axis) and second stimulation LTr2, (y-axis) for all studied cells in the three animal models respectively. Correlation coefficients, mean values, and numbers of experiments are shown in Table 1Go. Basal medium was switched to test medium at time 0 min.

 

Figure 2
View larger version (15K):
[in this window]
[in a new window]
 
Figure 2 Ca2+ responses from a representative isolated lean, ob/ob, and db/db mouse ß-cell during two consecutive stimulations with 20 µM tolbutamide. For experimental details, see Materials and Methods and legend of Fig. 1Go. Test medium contained 5 mM glucose. Correlation coefficients, mean values, and numbers of experiments are shown in Table 1Go.

 
Cell specificity of the ß-cell Ca2+ response to arginine

Arginine induced cell-specific Ca2+ responses in lean mouse ß-cells with regard to both timing and magnitude (Table 1Go). There was no correlation between lag times for calcium rise during the first and second stimulation in ß-cells from db/db or ob/ob mice but peak heights were cell-specific in db/db mouse ß-cells (Table 1Go). As with tolbutamide, the response in db/db mouse ß-cells occurred with shorter lag times than in lean mouse ß-cells and reached a lower magnitude.

Cell specificity of the insulin secretion in isolated ß-cells

We have also tested to what extent temporal cell specificity of the Ca2+ response is related to insulin release. Zn2+ is co-released with insulin and Zn2+ efflux was measured as a marker of insulin secretion (Frederickson & Bush 2001, Qian et al. 2003). The secretory response to 100 µM tolbutamide was recorded during the first stimulation and the Ca2+ response was recorded during the second stimulation (Fig. 3AGo). We found that the time of onset of the Zn2+ outflow correlated with the lag time for calcium rise in lean mouse ß-cells (Table 1Go, Fig. 3BGo) but not in ob/ob mouse ß-cells (Table 1Go, Fig. 3CGo). We have not compared the magnitudes of Zn2+ and Ca2+ response because Zn2+ dissolves quickly in the surrounding medium and the rise in Zn2+ outflow is difficult to estimate.


Figure 3
View larger version (13K):
[in this window]
[in a new window]
 
Figure 3 Ca2+ response and Zn2+ outflow from isolated ß-cells during two consecutive stimulations with 100 µM tolbutamide. For experimental details, see Materials and Methods. (A) Recordings of the Zn2+ outflow from a lean mouse ß-cell during the first stimulation (solid line) and the Ca2+ response during the second stimulation (dotted line). The resting period between stimulations was 30 min. (B and C) Correlation between lag time for Zn2+ outflow LTr1 (x-axis) and lag time for [Ca2+]i rise LTr2, (y-axis) in (B) lean and (C) ob/ob mouse ß-cells. Test medium contained 3 mM glucose. Correlation coefficients, mean values, and numbers of experiments are shown in Table 1Go. a.u., arbitrary unit.

 
Cell specificity of the Ca2+ response to tolbutamide in single ß-cells within intact islets

We studied responses from individual ß-cells on the periphery of Fluo-3-labeled intact islets (Fig. 4AGo) during two consecutive stimulations. Tolbutamide at 20 µM was chosen as the stimulus to get a larger variation in lag time for Ca2+rise. We tested 30 cells in six lean mouse islets and 87 cells in ten ob/ob mouse islets. Parameters were calculated as described for isolated ß-cells. ß-Cells within lean mouse islets showed cell-specific responses with a high degree of correlation between lag times during the first and second stimulation (Fig. 4CGo). Figure 4BGo shows representative traces from two cells. Within each islet, there was often only a small difference in lag time among individual cells and between the first and second stimulation (Table 1Go). PH1 and PH2 were correlated, but PH2 was lower than PH1 (Table 1Go). A lower PH2 could be due to dye degradation and/or leakage. However, we previously recorded a lower second response to glucose also using Fura-2 in intact islets (Pakhtusova et al. 2003).


Figure 4
View larger version (31K):
[in this window]
[in a new window]
 
Figure 4 Ca2+ responses from individual cells within lean and ob/ob mouse islets during two consecutive stimulations with 20 µM tolbutamide. (A) An image of a lean mouse islet loaded with Fluo-3 and stimulated with 20 µM tolbutamide+5 mM glucose; bar=20 µm. For clarity, the image was processed with a median filter (Leica Confocal Software) to minimize noise. (B) Recordings from two cells indicated by arrows in A. (C and D) Correlation between LTr1 (x-axis) and LTr2, (y-axis) in (C) lean and (D) ob/ob mouse ß-cells. For experimental details, see Materials and Methods and Results sections. Mean values, correlation coefficients, and numbers of experiments are presented in the Table 1Go.

 
ß-Cells within ob/ob mouse islets showed cell-specific timing of responses, but the lag time was longer during the second stimulation (Table 1Go, Fig. 4DGo). The average lag time (LTr1) was longer than in lean mouse (Table 1Go) and varied more between individual cells (0–350 in ob/ob mouse islets vs 0–128 in lean mouse islets). Peak heights showed no correlation and did not differ between stimulations. Thus, individual ß-cells within an ob/ob mouse islet showed temporal cell specificity of the Ca2+ response, although with a larger variation in lag time than lean mouse ß-cells.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We found earlier that normal mouse ß-cells show cell-specific Ca2+ responses when stimulated with glycolytic as well as with mitochondrial substrates (Gustavsson et al. 2005). Here we have shown that normal ß-cells have unique and reproducible, i.e., cell-specific, Ca2+ responses also to the nonmetabolic stimulators tolbutamide and arginine. This indicates cell specificity not only of the stimulus–secretion coupling as a whole, but also of different parts of it. While cell specificity seems to be a robust phenomenon in normal ß-cells, ob/ob and db/db mouse ß-cells show no cell-specific timing of Ca2+ response when stimulated with tolbutamide or arginine. The mechanism of action of arginine is a direct depolarization of the ß-cell membrane similar to that of cations (Charles et al. 1982, Herchuelz et al. 1984) and tolbutamide causes closure of K+ATP channels. Although we did not study ion channel function directly, the results suggest that the response of plasma membrane ion channels is also cell-specific in normal ß-cells. Cell-specific function of Ca2+ channels may be linked to the number of channels and/or differences in channel properties, such as the gating. Previous reports have shown different results regarding Ca2+ channel function in ß-cells from animals with conditions similar to type-2 diabetes. A reduction of L-type Ca2+ currents and a decreased expression of the {alpha} 1-subunit of L-type Ca2+ channels was observed in the Zucker diabetic fatty rat (Roe et al. 1996). Other studies report an increased activity of L-type Ca2+ channels in the Goto Kakisaki rat (Kato et al. 1996). A lower expression of Ca2+ channels could possibly explain the reduced Ca2+ response but not the loss of temporal cell specificity, which we found in db/db and ob/ob mouse ß-cells. This indicates that other alterations of Ca2+ channels are present in ß-cells hyperglycemic mice.

The failure of db/db and ob/ob mouse ß-cells to show cell-specific timing of response to a KATP-channel blocker (tolbutamide) may be due to increased activity of KATP channels and impaired electrical activity (Ashcroft & Rorsman 2004). The cell-specific magnitude of the response to tolbutamide in ß-cells from hyperglycemic mouse indicates that timing and magnitude of the Ca2+ response are controlled by different mechanisms.

Type-2 diabetic ß-cells show a delayed Ca2+ response to glucose but not to arginine or sulfonylureas (Zaitsev et al. 1997, Del Guerra et al. 2005). In fact ß-cells from db/db mice responded to tolbutamide and arginine with a shorter lag time than lean mouse ß-cells and a similar tendency was found also in ob/ob mouse ß-cells. The magnitude of the response was lower in db/db mouse ß-cells with both nutrient (Roe et al. 1994, Gustavsson et al. 2005) and non-nutrient stimulators (this report). It may be that chronic hyperglycemia slows down the metabolic rate but increases the sensitivity of K+ATP or Ca2+ channels (Kato et al. 1996).

The lag time for Ca2+ rise was longer in response to 20 µM tolbutamide when compared with 100 µM, but the magnitudes of response and the patterns of [Ca2+]i changes were similar. There have been no studies aimed at comparing the timing of ß-cell depolarization when different concentrations of sulfonylureas are used. However, in the paper by Henquin (1998), recordings of electrical responses to 15, 25, and 100 µM tolbutamide were shown. From the data, it appears that the depolarization is slower with 15 µM, but does not differ between 25 and 100 µM tolbutamide (Henquin 1998). The longer lag time for calcium rise to 20 µM tolbutamide is therefore likely to be caused by a slower depolarization. The difference is probably not related to the difference in glucose concentration in the stimulatory solution, because an increase in glucose concentration would induce a quicker response.

The peak height during the second stimulation was smaller in ob/ob mouse ß-cells than in lean mouse cells (Table 1Go). Cells may be desensitized by the previous exposure to sulfonylureas (McClenaghan et al. 2000), but it is difficult to explain the fact that only mice with a milder hyperglycemic syndrome but not severely diabetic mice develop the desensitization.

The timing of Zn2+ outflow recorded during the first stimulation with tolbutamide in lean mouse ß-cells correlated with the timing of Ca2+response recorded during the second stimulation. We showed that ß-cells repeat their Ca2+ response pattern during consecutive stimulations with tolbutamide. It has also been found that cytoplasmic calcium changes and Zn2+release are linked with regard to both timing and magnitude (Qian et al. 2004). With the assumption that the timing of insulin release is correlated to the lag time for Ca2+ response also during consecutive stimulations we can, therefore, conclude that the timing of insulin release to tolbutamide is cell-specific in normal mouse ß-cells. No such correlation was found in ob/ob mouse ß-cells. Most likely, this is coupled to the lack of cell specificity for Ca2+ responses to tolbutamide.

It was recently claimed that cells within an islet show identical temporal responses (Kuznetsov et al. 2005). We could identify fast and slow responding cells within both lean and ob/ob mouse islets. The variation was rather small in lean mouse islets, but in ob/ob mouse islets the range of lag times was almost as large as in isolated ß-cells. This could be due to a disturbed stimulus–secretion coupling or to a damage of cell contacts and may explain the disorganization of [Ca2+]i oscillations found in ob/ob mouse islets (Ravier et al. 2002). ß-Cells both within intact lean and ob/ob mouse islets showed cell-specific timing of their Ca2+ responses to tolbutamide. Thus, cell-specific timing of response to tolbutamide can be observed in functionally coupled, but not in isolated ß-cells from ob/ob mice. This supports the hypothesis that some ß-cells have a pacemaker function. ß-Cells may vary in their functional characteristics, because ß-cells within pancreatic islets originate not from a single stem cell but from a number of different low-differentiated precursors (Lechner & Habener 2003). We have previously reported that intact islets as a whole show a specific response (Pakhtusova et al. 2003). Taken together, this indicates that both the cell specificity of each ß-cell and the functional connection between cells is important for islet-specific behavior and adequate insulin release.

Normal ß-cells show cell-specific responses with all tested stimuli. ß-Cells from hyperglycemic mice have shown cell-specific timing and magnitude of responses to glucose and glyceraldehyde, but they have lost their temporal cell specificity when stimulated with a mitochondrial substrate, which suggested an altered mitochondrial function (Gustavsson et al. 2005). The loss of cell-specific timing of response also at the step of Ca2+ channel opening suggests that the mechanism(s) for setting the individual response characteristics is impaired in diabetic mouse ß-cells. Therefore, cell specificity for all steps of the stimulus–secretion coupling may be important for normal function.

ß-Cells constitute more than 90% of the cells islet ob/ob mice and about 70% in normal mouse islets. The proportion of ß-cells in islets from severely diabetic mice is reduced (Baetens et al. 1978). Therefore, it is possible that many of the cultured cells were non-ß-cells in the latter two mouse models. However, cells included in this study showed [Ca2+]i responses to tolbutamide, tolbutamide in combination with glucose, and arginine that were all typical for ß-cells (Berts et al. 1996, Quesada et al. 1999).

In conclusion, normal ß-cells show cell-specific Ca2+ responses when stimulated with nonmetabolic agents. The lag time is not cell-specific in tolbutamide- and arginine-stimulated isolated ß-cells from hyperglycemic mice. Cell specificity seems to be a robust mechanism, which is probably necessary for an adequate ß-cell function.


    Acknowledgements
 
This work was supported by the Swedish Research Council (12X-4756), the Swedish Diabetes Association, the Sahlberg Foundation, the Lars Hiertas Foundation and the Medical Faculty, Umeå University. The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Ashcroft SJ & Ashcroft FM 1992 The sulfonylurea receptor. Biochimica et Biophysica Acta 1175 45–59.[Medline]

Ashcroft F & Rorsman P 2004 Type 2 diabetes mellitus: not quite exciting enough? Human Molecular Genetics 13 (Spec No 1) R21–R31.[Abstract/Free Full Text]

Baetens D, Stefan Y, Ravazzola M, Malaisse-Lagae F, Coleman DL & Orci L 1978 Alteration of islet cell populations in spontaneously diabetic mice. Diabetes 27 1–7.[Abstract]

Berglund O, Frankel BJ & Hellman B 1978 Development of the insulin secretory defect in genetically diabetic (db/db) mouse. Acta Endocrinologica 87 548–551.

Berts A, Ball A, Gylfe E & Hellman B 1996 Suppression of Ca2+ oscillations in glucagon-producing alpha 2-cells by insulin/glucose and amino acids. Biochimica et Biophysica Acta 1310 212–216.[Medline]

Cerasi E, Luft R & Efendic S 1972 Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes 21 224–234.[Web of Science][Medline]

Charles S, Tamagawa T & Henquin J-C 1982 A single mechanism for the stimulation of insulin release and 86Rb+ efflux from rat islets by cationic amino acids. Biochemical Journal 208 301–308.[Web of Science][Medline]

Del Guerra S, Lupi R, Marselli L, Masini M, Bugliani M, Sbrana S, Torri S, Pollera M, Boggi U, Mosca F, Del Prato S & Marchetti P 2005 Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54 727–735.[Abstract/Free Full Text]

Frederickson CJ & Bush AI 2001 Synaptically released zinc: physiological functions and pathological effects. Biometals 14 353–366.[CrossRef][Web of Science][Medline]

Gee KR, Zhou ZL, Qian WJ & Kennedy R 2002 Detection and imaging of zinc secretion from pancreatic beta-cells using a new fluorescent zinc indicator. Journal of the American Chemical Society 124 776–778.[CrossRef][Web of Science][Medline]

Grapengiesser E, Gylfe E & Hellman B 1988 Dual effect of glucose on cytoplasmic Ca2+ in single pancreatic beta-cells. Biochemical and Biophysical Research Communications 150 419–425.[CrossRef][Web of Science][Medline]

Grynkiewicz G, Poenie M & Tsien RY 1985 A new generation of Ca2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry 260 3440–3450.[Abstract/Free Full Text]

Gustavsson N, Larsson-Nyrén G & Lindström P 2005 Pancreatic ß-cells from db/db mice show cell-specific [Ca2+]i and NADH responses to glucose but not to alpha-ketoisocaproic acid. Pancreas 31 242–250.[CrossRef][Web of Science][Medline]

Hellman B, Idahl L-Ä, Lernmark Ä, Sehlin J & Täljedal I-B 1974 The pancreatic beta-cell recognition of insulin secretagogues. Effects of calcium and sodium on glucose metabolism and insulin release. Archives of Biochemistry and Biophysics 162 448–457.[CrossRef][Web of Science][Medline]

Hellman B, Dansk H & Grapengiesser E 2004 Pancreatic beta-cells communicate via intermittent release of ATP. American Journal of Physiology – Endocrinology and Metabolism 286 E759–E765.

Henquin J-C 1998 A minimum of fuel is necessary for tolbutamide to mimic the effects of glucose on electrical activity in pancreatic beta-cells. Endocrinology 139 993–998.[Abstract/Free Full Text]

Herchuelz A, Lebrun P, Boschero AC & Malaisse WJ 1984 Mechanism of arginine-stimulated Ca2+ influx into pancreatic B cell. American Journal of Physiology 246 E38–E43.[Medline]

Herchuelz A, Pochet R, Pastiels C & Van Praet A 1991 Heterogeneous changes in [Ca2+]i induced by glucose, tolbutamide and K+ in single rat pancreatic B cells. Cell Calcium 12 577–586.[CrossRef][Web of Science][Medline]

Idahl L-Ä, Lernmark Ä , Sehlin J & Täljedal I-B 1976 Studies on the function of pancreatic islet cell membranes. Journal of Physiology 72 729–746.

Jonkers FC, Guiot Y, Rahier J & Henquin J-C 2001 Tolbutamide stimulation of pancreatic beta-cells involves both cell recruitment and increase in the individual Ca(2+) response. British Journal of Pharmacology 133 575–585.[CrossRef][Web of Science][Medline]

Kato S, Ishida H, Tsuura Y, Tsuji K, Nishimura M, Horie M, Taminato T, Ikehara S, Odaka H, Ikeda I et al. 1996 Alterations in basal and glucose-stimulated voltage-dependent Ca2+ channel activities in pancreatic beta cells of non-insulin-dependent diabetes mellitus GK rats. Journal of Clinical Investigation 97 2417–2425.[Web of Science][Medline]

Kay AR et al. 2004 Detecting and minimizing zinc contamination in physiological solutions. BMC Physiology 4 4.[CrossRef][Medline]

Kuznetsov A, Bindokas VP, Marks JD & Philipson LH 2005 FRET-based voltage probes for confocal imaging: membrane potential oscillations throughout pancreatic islets. Americal Journal of Physiology – Cell Physiology 289 C224–C229.

Larsson-Nyrén G & Sehlin J 1996 Comparison of the effects of perchlorate and Bay K 8644 on the dynamics of cytoplasmic Ca2+ concentration and insulin secretion in mouse ß-cells. Biochemical Journal 314 167–173.

Larsson-Nyrén G, Pakhtusova N & Sehlin J 2002 Isolated mouse pancreatic beta-cells show cell-specific temporal response pattern. American Journal of Physiology – Cell Physiology 282 C1199–C1204.

Lechner A & Habener JF 2003 Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. American Journal of Physiology – Endocrinology and Metabolism 284 E259–E266.

Lernmark Ä 1974 The preparation of and studies on free cell suspensions from mouse pancreatic islets. Diabetologia 10 431–438.[CrossRef][Web of Science][Medline]

McClenaghan NH, Ball AJ & Flatt PR 2000 Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamide. British Journal of Pharmacology 30 478–484.[CrossRef]

Nadal A, Quesada I & Soria B 1999 Homologous and heterologous asynchronicity between identified alpha-, beta- and delta-cells within intact islets of Langerhans in the mouse. Journal of Physiology 517 85–93.[Abstract/Free Full Text]

Nesher R, Eylon L, Segal N & Cerasi E 1989 Beta-cell memory to insulin secretagogues: characterization of the time-dependent inhibitory control system in the isolated rat pancreas. Endocrinology 124 142–148.[Abstract/Free Full Text]

Pakhtusova N, Zaostrovskaya L, Lindström P & Larsson-Nyrén G 2003 Cell-specific Ca(2+) responses in glucose-stimulated single and aggregated beta-cells. Cell Calcium 34 121–129.[CrossRef][Web of Science][Medline]

Pipeleers D, Kiekens R, Ling Z, Wilikens A & Schuit F 1994 Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 37 (Suppl 2) 57–64.

Porte D Jr 1991 ß-Cells in type II diabetes mellitus. Diabetes 40 166–180.[Abstract]

Pralong WF, Bartley C & Wollheim CB 1990 Single islet beta-cell stimulation by nutrients: relationship between pyridine nucleotides, cytosolic Ca2+and secretion. EMBO Journal 9 53–60.[Web of Science][Medline]

Qian WJ, Gee KR & Kennedy RT 2003 Imaging of Zn2+ release from pancreatic beta-cells at the level of single exocytotic events. Analytical Chemistry 75 3468–3475.[Medline]

Qian WJ, Peters JL, Dahlgren GM, Gee KR & Kennedy RT 2004 Simultaneous monitoring of Zn2+ secretion and intracellular Ca2+ from islets and islet cells by fluorescence microscopy. Biotechniques 37 922–924, 926, 928–930 passim.[Web of Science][Medline]

Quesada I, Nadal A & Soria B 1999 Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. Diabetes 48 2390–2397.[Abstract]

Ravier MA, Sehlin J & Henquin J-C 2002 Disorganization of cytoplasmic Ca(2+) oscillations and pulsatile insulin secretion in islets from ob/ob mice. Diabetologia 45 1154–1163.[CrossRef][Web of Science][Medline]

Roe MW, Philipson LH, Frangakis CJ, Kuznetsov A, Mertz RJ, Lancaster ME, Spencer B, Worley JF 3rd & Dukes ID 1994 Defective glucose-dependent endoplasmic reticulum Ca2+sequestration in diabetic mouse islets of Langerhans. Journal of Biological Chemistry 269 18279–18282.[Abstract/Free Full Text]

Roe MW, Worley JF 3rd, Tokuyama Y, Philipson LH, Sturis J, Tang J, Dukes ID, Bell GI & Polonsky KS 1996 NIDDM is associated with loss of pancreatic beta-cell L-type Ca2+ channel activity. Americal Journal of Physiology 270 E133–E140.

Salomon D & Meda P 1986 Heterogeneity and contact-dependent regulation of hormone secretion by individual ß cells. Experimental Cell Research 162 507–520.[CrossRef][Web of Science][Medline]

Trube G, Rorsman P & Ohno-Shosaku T 1986 Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. Pflugers Archive 407 493–499.

Zaitsev S, Efanova I, Ostenson CG, Efendic S & Berggren PO 1997 Delayed Ca2+ response to glucose in diabetic GK rat. Biochemical and Biophysical Research Communications 239 129–133.[CrossRef][Web of Science][Medline]

Received in final form 10 April 2006
Accepted 25 April 2006
Made available online as an Accepted Preprint 10 May 2006





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gustavsson, N.
Right arrow Articles by Lindström, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gustavsson, N.
Right arrow Articles by Lindström, P.


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS